Terms: = Leukemia AND SPECC1, FLJ36955, CYTSB, 92521, ENSG00000128487, Q5M775, NSP, HCMOGT-1
12 results:
1. Exploring the in vivo anti-cancer potential of Neosetophomone B in leukemic cells using a zebrafish xenograft model.
Kuttikrishnan S; Hasan M; Prabhu KS; El-Elimat T; Oberlies NH; Pearce CJ; Alali FQ; Ahmad A; Pourkarimi E; Bhat AA; Yalcin HC; Uddin S
Exp Cell Res; 2024 Feb; 435(1):113907. PubMed ID: 38184222
[TBL] [Abstract] [Full Text] [Related]
2. Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases.
Kakavandi S; Zare I; VaezJalali M; Dadashi M; Azarian M; Akbari A; Ramezani Farani M; Zalpoor H; Hajikhani B
Cell Commun Signal; 2023 May; 21(1):110. PubMed ID: 37189112
[TBL] [Abstract] [Full Text] [Related]
3. Anticancer activity of Neosetophomone B by targeting AKT/SKP2/MTH1 axis in leukemic cells.
Kuttikrishnan S; Bhat AA; Mateo JM; Ahmad F; Alali FQ; El-Elimat T; Oberlies NH; Pearce CJ; Uddin S
Biochem Biophys Res Commun; 2022 Apr; 601():59-64. PubMed ID: 35228122
[TBL] [Abstract] [Full Text] [Related]
4. Circ_0000745 promotes acute lymphoblastic leukemia progression through mediating miR-494-3p/NET1 axis.
Yang X; Li Y; Zhang Y; Liu J
Hematology; 2022 Dec; 27(1):11-22. PubMed ID: 34957935
[TBL] [Abstract] [Full Text] [Related]
5. In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation.
Hossain R; Sarkar C; Hassan SMH; Khan RA; Arman M; Ray P; Islam MT; Daştan SD; Sharifi-Rad J; Almarhoon ZM; Martorell M; Setzer WN; Calina D
Chin J Integr Med; 2022 Mar; 28(3):249-256. PubMed ID: 34913151
[TBL] [Abstract] [Full Text] [Related]
6. A novel PAX5 rearrangement in TCF3-PBX1 acute lymphoblastic leukemia: a case report.
Barbosa TC; Lopes BA; Blunck CB; Mansur MB; Deyl AVS; Emerenciano M; Pombo-de-Oliveira MS
BMC Med Genomics; 2018 Dec; 11(1):122. PubMed ID: 30563523
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition of Nucleotide Synthesis Targets Brain Tumor Stem Cells in a Subset of Glioblastoma.
Laks DR; Ta L; Crisman TJ; Gao F; Coppola G; Radu CG; Nathanson DA; Kornblum HI
Mol Cancer Ther; 2016 Jun; 15(6):1271-8. PubMed ID: 27196770
[TBL] [Abstract] [Full Text] [Related]
8. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
[TBL] [Abstract] [Full Text] [Related]
9. Sorting, identification and enrichment of side population cells in THP-1 acute monocytic leukemia cells.
Wang Y; Yin C; Feng L; Ma L; Wei Y; Sheng G
Oncol Rep; 2013 May; 29(5):1923-31. PubMed ID: 23450319
[TBL] [Abstract] [Full Text] [Related]
10. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
[TBL] [Abstract] [Full Text] [Related]
11. Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K nsp, and SNP6.0 arrays.
Hagenkord JM; Monzon FA; Kash SF; Lilleberg S; Xie Q; Kant JA
J Mol Diagn; 2010 Mar; 12(2):184-96. PubMed ID: 20075210
[TBL] [Abstract] [Full Text] [Related]
12. hcmogt-1 is a novel fusion partner to PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2).
Morerio C; Acquila M; Rosanda C; Rapella A; Dufour C; Locatelli F; Maserati E; Pasquali F; Panarello C
Cancer Res; 2004 Apr; 64(8):2649-51. PubMed ID: 15087372
[TBL] [Abstract] [Full Text] [Related]
